key: cord-0920619-wjm6rraa
authors: Roifman, Idan; Arora, Rakesh C.; Bewick, David; Chow, Chi-Ming; Clarke, Brian; Cowan, Simone; Ducharme, Anique; Gin, Kenneth; Graham, Michelle; Gupta, Anil; Hardiman, Sean; Hartleib, Michael; Jackson, Simon; Jassal, Davinder; Kazmi, Mustapha; Lamarche, Yoan; Légaré, Jean-François; Leong-Poi, Howard; Mansour, Samer; Marelli, Ariane; Ruel, Marc; Small, Gary; Sterns, Larry; Turgeon, Ricky; Virani, Sean; Wijeysundera, Harindra C.; Wong, Kenny; Wood, David A.; Zieroth, Shelley; Singh, Gurmeet; Krahn, Andrew D.
title: Cardiovascular care delivery during the second wave of COVID-19 in Canada
date: 2020-12-09
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2020.11.016
sha: c0e95d489c07366407bb48d6a2a39552106b5475
doc_id: 920619
cord_uid: wjm6rraa

Hospitals and ambulatory facilities significantly reduced cardiac care delivery in response to the first wave of the COVID-19 pandemic. The deferral of elective cardiovascular procedures led to a marked reduction in healthcare delivery with a significant impact on optimal cardiovascular care. International and Canadian data have reported dramatically increased wait-times for diagnostic tests and cardiovascular procedures, as well as associated increased cardiovascular morbidity and mortality. In the wake of the demonstrated ability to rapidly create critical care and hospital ward capacity, we advocate a different approach during the second and possible subsequent COVID-19 pandemic waves. We suggest an approach, informed by local data and experience, which balances the need for an expected rise in demand for healthcare resources to ensure appropriate COVID-19 surge capacity, with continued delivery of essential cardiovascular care. Incorporating cardiovascular care leaders into pandemic planning and operations will help healthcare systems minimize cardiac care delivery disruptions, while maintaining critical care and hospital ward surge capacity and continuing measures to reduce transmission risk in healthcare settings. Specific recommendations targeting the main pillars of cardiovascular care are presented: ambulatory, inpatient, procedural, diagnostic, surgical and rehabilitation.

Hospitals and ambulatory facilities significantly reduced cardiac care delivery in response to the 2 first wave of the COVID-19 pandemic. The deferral of elective cardiovascular procedures led to 3 a marked reduction in healthcare delivery with a significant impact on optimal cardiovascular 4 care. International and Canadian data have reported dramatically increased wait-times for 5 diagnostic tests and cardiovascular procedures, as well as associated increased cardiovascular 6 morbidity and mortality. 7

In the wake of the demonstrated ability to rapidly create critical care and hospital ward capacity, 8

we advocate a different approach during the second and possible subsequent COVID-19 9 pandemic waves. We suggest an approach, informed by local data and experience, which 10 balances the need for an expected rise in demand for healthcare resources to ensure appropriate 11 COVID-19 surge capacity, with continued delivery of essential cardiovascular care. In March, 2020, hospitals and ambulatory facilities significantly reduced cardiac care delivery in 2 preparation for a surge of COVID-19. Procedures such as non-invasive diagnostic tests, 3 angiograms, percutaneous coronary interventions (PCIs), heart rhythm devices and ablations, and 4 cardiac surgeries were severely restricted, only performed on an urgent or emergent basis. The 5 deferral of elective procedures led to a significant impact on optimal cardiac care and resulted in 6 backlogs for cardiac procedures and diagnostic tests. 1 Specific Canadian data regarding the 7 extent of these backlogs are currently being compiled and have not yet been published. 8

International data has reported increased cardiovascular morbidity and mortality during the first 9

wave of healthcare lockdowns. 2 Emerging Canadian data similarly suggested cardiovascular 10 morbidity and mortality increased during the first wave of COVID-19. 3 Healthcare teams 11 demonstrated an ability to create emergency operations teams to oversee the creation of rapid 12 and safe care delivery. Such teams are key to balance preparedness, as COVID-19 case volumes 13 increase, with the cost of deferred cardiovascular care and its associated consequences. 14 As a result of lessons learned during the first COVID-19 wave, we advocate a different approach 15 during the second and subsequent pandemic waves. We suggest an approach, informed by local 16 data and experience, which balances the need for an expected rise in demand for healthcare 17 resources to ensure COVID-19 surge capacity, with continued delivery of needed cardiovascular 18 care. In order to help preserve the capacity of our healthcare system, cardiovascular care 19 providers should advocate and practice infection mitigation strategies such as physical 20 distancing, hand hygiene and staying home when unwell. By incorporating cardiovascular care 21 leaders into pandemic planning and operations, healthcare systems can minimize cardiovascular 22 care delivery disruptions, while maintaining critical care surge capacity. Importantly, 23 cardiovascular health service delivery should follow the guiding principles of fairness (follow a 1 fair priority setting process that is relevant, transparent, and engages all relevant stakeholders), 2 balance (balance priorities such as human resources and limited physical resources such as PPE 3 and medications) and equity (manage all people presenting with similar priority problems in the 4 same manner). These principles should apply nationally, and be free from political 5 considerations. The following recommendations based on consensus are provided for the key 6 pillars of cardiovascular care. 7 RECOMMENDATIONS: 8

In order to protect the fragile population with cardiovascular disease, shifting towards 10 hybrid care models with virtual care components, and in some instances remote monitoring, 11 was initiated during the first wave of COVID-19. Coordinated efforts between health 12 systems and cardiovascular leaders created new virtual capacity for those requiring 13 emergency care or in-person management. High-quality remote ambulatory care is feasible 14 for a great proportion of cardiovascular patients, providing timely access to local 15 laboratories, unencumbered access to guideline directed medical therapy, and up-to-date 16 information systems. 4 However, there is significant variability in resources for remote 17 healthcare infrastructure across the country. Government should prioritize and invest in 18 enhancing this capacity. There is a concurrent need to ensure that high-risk patients cannot 19 be delayed in-person evaluation and investigation. This approach is crucial to prevent the 20 unintended consequence of increased morbidity and mortality due to acute presentations of 21 heart failure, acute coronary syndromes, and syncope. cardiac patient access to critical care. It is recommended that the perioperative team develop 7 a location and process to safely care for cardiac surgery patients in an environment that is 8 able to maintain strict COVID-19 infection mitigation protocols. Cardiology inpatient 9 capacity may also be significantly impacted by surge capacity aimed at ensuring adequate 10 bed resources for non-critically ill hospitalized COVID-19 patients. Individual health care 11 system decisions regarding inpatient ward and critical care resources should factor in 12 cardiovascular patient acuity and flow. To this end, strategic bed allocation will benefit from 13 cardiovascular leader participation during pandemic logistical planning. 14 3. Procedural Care: The majority of needed procedural care can continue without impact 15 on the necessary in-hospital bed capacity that may be required for a potential COVID-19 16 surge. Redeployment of health care workers may impact the ability to perform procedural 17 care. Scheduling of shared resources for procedural care must be sufficiently nimble to 18 address increasing wait-lists in areas such as electrophysiology (EP) ablations and TAVR 19 while concurrently being able to address acute needs such as cardiac device implants, 20 diagnostic angiography, or PCI. This will require new models of cardiac catheterization lab 21 operations that emphasize flexibility. For example, in order to balance outpatient wait-lists 22 while concurrently addressing urgent cases across procedures, blending planned elective 23 case mixes may be considered (intervention and electrophysiology), while ensuring reserve 1 capacity for urgent and emergent cases. 2

It is essential that access to diagnostic cardiac testing is maintained. However, the potential 4 increased risk of exposure and infection highlights the importance of following appropriate 5 use criteria. This applies to both ambulatory and inpatient testing, including 6 electrocardiography (ECG), Holter monitoring, stress testing, echocardiography, nuclear 7 imaging, cardiac computed tomography (CCT), and cardiac magnetic resonance imaging 8 (CMR). Appropriate diagnostic testing may involve utilization rates at or near pre-pandemic 9 levels, although a modest reduction in testing may be necessary during surges if hospital 10 resources and staff are redeployed for COVID-19 clinical activities. During periods of 11 constrained hospital resources, patients may be triaged based on test indication. When 12 deciding which modality has the best capability to answer the clinical query, the risk of 13 infection and contamination for patients, health care workers, and infrastructure, should also 14 be considered in the decision making process. Specifically, the American College of 15

Cardiology and American Society of Echocardiography consider trans-esophageal 16 echocardiography (TEE) to be an aerosol generating procedure which requires additional 17 consideration of its incremental value over trans-thoracic echocardiography (TTE Finally, we recommend that local health centres consider establishing expert panels to 1 oversee test triage processes to ensure appropriate indications and urgency, in line with local 2 capacity and expertise. 3

Surges in COVID-19 cases impact the ability to provide surgery for life-threatening 5 cardiovascular conditions. It is likely that health systems will face cyclical phases of 6 reducing and ramping up cardiac surgical activity, with ongoing strain on healthcare 7 resources, access to care, and provider teams. While there is a clear need to maintain 8 emergency services, it is also essential to ensure that those awaiting non-urgent surgery are 9 closely followed and regularly triaged to undergo surgery as expeditiously as resources 10 allow. Preliminary data compiled from the University Health Network in April 2020 11 estimated that 35 deaths may have been attributable to delays in scheduled cardiac surgeries. 12

In the initial phases of the pandemic, many centres optimized capacity by adjusting case 13 volumes up and down, relatively rapidly. This strategy provided capacity for patients with 14 severe COVID-19-related illness that required critical care resources, while continuing to 15 offer cardiac surgery services. Therefore, the ability to predict ICU length of stay after 16 cardiac surgery may be useful, as it helps to predict ramp-down capacity. 5 When strained 17 beyond local capacity, cardiac surgery and critical care teams should consider referral 18 beyond the usual healthcare institutions, regions and/or provincial boundaries, with 19 collaboration from governments and less-affected centres. 20 6. Rehabilitation Care: The cardiovascular community adapted cardiac rehabilitation (CR) 21 strategies during the initial wave of the COVID-19 pandemic. Unable to continue the 22 traditional transition from in-hospital care to onsite cardiac rehabilitation (CR), most 23

Canadian programs developed various degrees of a virtual patient-centric model. This 1 format blended limited face-to-face encounters with scheduled meetings. Home-Based CR 2 (HBCR) has enabled overcoming many long-established barriers encountered with on-site 3 programs, including access, distance, elderly, minorities, and the socioeconomically 4 disadvantaged. Challenges persist with HBCR, however. When it is not possible to offer 5 conventional symptom-limited exercise treadmill testing prior to initiating a prescribed 6 exercise program, alternative methods to assess functional capacity are needed. In particular, 7 an emphasis on patient education for alarming symptoms, and acceptance of reduced 8 exercise intensity is required. CR programs must adapt to the "ebb and flow" imposed by 9 COVID-19 to prevent significant gaps of care delivery. 10

To ameliorate challenges with cardiovascular care access and delivery during COVID-19, 12 incorporating cardiovascular leadership into pandemic planning with operational leaders 13 will assist in minimizing cardiovascular care delivery disruptions, while maintaining critical 14 care and inpatient surge capacity. 

Optimizing Care Through COVID-19 Transmission Scenarios-2

Care-Through-COVID-19-Transmission-Scenarios.pdf. Guidance document: 4 Government of Ontario

Deaths From COVID-19 and Other Causes

COVID-19 Pandemic: Global Impact and 9

Potential Implications for Cardiovascular Disease in Canada

Optimizing Access to Heart Failure Care in 11

Canada During the COVID-19 Pandemic

Derivation and Validation 13 of a Clinical Model to Predict Intensive Care Unit Length of Stay After Cardiac Surgery